Mitchell P. Kopin 13D/13G Filings for Can-Fite BioPharma Ltd. (CANF)

Mitchell P. Kopin 13D and 13G filings for Can-Fite BioPharma Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
06:52 am
Purchase		 2021-12-31 13G Can-Fite BioPharma Ltd.
CANF		 Mitchell P. Kopin 394,954,370
4.990%		 65,837,870increase
(+20.00%)		 Filing
2021-01-29
06:51 am
Purchase		 2020-12-31 13G Can-Fite BioPharma Ltd.
CANF		 Mitchell P. Kopin 329,116,500
6.600%		 325,475,470increase
(+8939.10%)		 Filing